EPISODE · May 26, 2026 · 1 MIN
Setidegrasib Shows Early Promise in Advanced Lung and Pancreatic Cancers
from TheBrief.Health · host TheBrief.Health
Setidegrasib, a novel KRAS G12D-targeted protein degrader, showed promising tumor responses in pancreatic and lung cancers, advancing precision oncology and personalized cancer treatment strategies.
What this episode covers
Setidegrasib, a novel KRAS G12D-targeted protein degrader, showed promising tumor responses in pancreatic and lung cancers, advancing precision oncology and personalized cancer treatment strategies.
NOW PLAYING
Setidegrasib Shows Early Promise in Advanced Lung and Pancreatic Cancers
No transcript for this episode yet
Similar Episodes
Apr 21, 2026 ·13m
Apr 19, 2026 ·16m
Apr 17, 2026 ·13m
Apr 13, 2026 ·11m
Apr 11, 2026 ·16m